Get startedLog in
    Picture of Spago Nanomedical AB (publ) logo

    SPAGO — Spago Nanomedical AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Spago Nanomedical Preclinical Results Show Reduced Tumor Growth With TUMORAD®

    Picture of Spago Nanomedical AB (publ) logoSpago Nanomedical AB (publ)
    25/01/2022 08:11
    Jan 25 (Reuters) - Spago Nanomedical publ AB  SPAGO.ST 
    * SIGNIFICANTLY REDUCED TUMOR GROWTH WITH TUMORAD® ACCORDING
TO
NEW PRECLINICAL RESULTS

Source text for Eikon:  ID:nMFN1FW0cW 
Further company coverage:  SPAGO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Spago Nanomedical AB (publ)

    See all news